0A43 trade ideas
Sustainability is the word for this company 1. $901 million net loss
2. No marketable product
3. At losing end compared with Moderna, Pfizer and others
So, if the FDA within the next month or so approves it vaccine trial, it might boost the share price temporarily but in the long term, it has to have a better strategy to compete with the bigger boys.
That means, if I wanna long, it will be more of a speculative trade than investment for the long term.
Bullish Trending Up5day MA crossing over the 8day MA, both are arching upward. Look to other instances of this occurrence and generally is followed by a spike in price action. I expect this should break out above $13 by next week.
The sell off this week was due to the entire market sell off after it was revealed in a secret memo that MM’s were notified before the market collapse back in April and the crash was due to a massive short sell. This has nothing to do with Inovio who also just filed a new 8K report disclosing the termination of an exclusive licensing agreement with GeneOne/VXG, (their long time manufacturing partner)for the Inovio’s Cellectra DNA Vaccine Delivery Smart Device. This is great news, because Inovio will now be able to licenses its use to other global suppliers. This is key as their medicine is next-generation with the proven ability to cure many major diseases such as cancers, HIV, Ebola, Covid-19. The medicines all must be administered with this proprietary DNA Medicine delivery device.
The age of DNA medicine is here.
INO potential targets and datesINO has been struggling lately, but the chart shows a clean falling wedge breakout and touch back to support, (yellow wedge and target). And a potential larger breakout wedge to the second target (green wedge and target) Both ideas work in unison. Both targets are on their potential dates as well
Set for a major rebound on major new catalystsBullish pennant formed just prior to FDA putting a partial hold on Inovio's Covid-19 vaccine P2/P3 trials.
Inovio is expected to resolve the FDA's questions within the next 30 days and begin trials with "EXTENSIVE external funding" according to CEO - Dr. Joseph Kim
Falling WedgeThe Falling Wedge is a bullish pattern that begins wide at the top and contracts as prices move lower. This price action forms a cone that slopes down as the reaction highs and reaction lows converge. In contrast to symmetrical triangles, which have no definitive slope and no bias, falling wedges definitely slope down and have a bullish bias. However, this bullish bias cannot be realized until a resistance breakout occurs.
A Falling Wedge fit into a reversal pattern at the bottom, but can also fit into the continuation category. As a continuation pattern, the falling wedge will still slope down, but the slope will be against the prevailing uptrend. As a reversal pattern, the falling wedge slopes down and with the prevailing trend. Regardless of the type (reversal or continuation), falling wedges are regarded as bullish patterns.
A falling or Rising wedge differs from a pennant or a flag in that it takes 3 weeks or more to form
INO has broken up and out of the FW pattern. There is also gaps and resistance overhead
Just an observation and no recommndation intended
INOVIO C wave completeHello Traders, Inovia appears to have completed a C wave by tagging the .786 and making a nice double U to launch for some upward trajectory price action. Some targets are shown and I expect the diagonal trendline to pose resistance as well as yellow horizontals. Good luck!
Not financial advice.